SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Daniel Nils Gotthardt, Helge Bruns, Karl Heinz Weiss, Peter Schemmer, Current strategies for immunosuppression following liver transplantation, Langenbeck's Archives of Surgery, 2014,

    CrossRef

  2. 2
    Taizo Hibi, Seigo Nishida, Junichiro Sageshima, David M. Levi, Phillip Ruiz, David Roth, Paul Martin, Koji Okabayashi, George W. Burke, Gaetano Ciancio, Andreas G. Tzakis, Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C, Transplant International, 2014, 27, 6
  3. 3
    Michael R. Charlton, Improving Long-Term Outcomes After Liver Transplantation, Clinics in Liver Disease, 2014, 18, 3, 717

    CrossRef

  4. 4
    Geoffrey W McCaughan, Kenny Ching Pan Sze, Simone I Strasser, Is there such a thing as protocol immunosuppression in liver transplantation?, Expert Review of Gastroenterology & Hepatology, 2014, 1

    CrossRef

  5. 5
    Mitsuhisa Takatsuki, Akihiko Soyama, Susumu Eguchi, Liver transplantation for HIV/hepatitis C virus co-infected patients, Hepatology Research, 2014, 44, 1
  6. You have free access to this content6
    Susumu Eguchi, Mitsuhisa Takatsuki, Tamotsu Kuroki, Liver transplantation for patients with human immunodeficiency virus and hepatitis C virus co-infection: update in 2013, Journal of Hepato-Biliary-Pancreatic Sciences, 2014, 21, 4
  7. You have free access to this content7
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of HCV transplant patients with triple therapy, Liver International, 2014, 34,
  8. 8
    Shunji Nagai, Atsushi Yoshida, Keisuke Kohno, David Altshuler, Mio Nakamura, Kimberly A. Brown, Marwan S. Abouljoud, Dilip Moonka, Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation, Hepatology, 2014, 59, 1
  9. 9
    Mostafa K. El Awady, Noha G. Bader El Din, Mahmoud Abdel Aziz Riad, Moataza H. Omran, Tawfeek H. Abdelhafez, Tamer Mahmoud Elbaz, Shereen Shoukry Hunter, Reham M. Dawood, Ashraf O. Abdel Aziz, Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients, Disease Markers, 2014, 2014, 1

    CrossRef

  10. 10
    P. Manousou, E. Cholongitas, D. Samonakis, E. Tsochatzis, A. Corbani, A. P. Dhillon, J. Davidson, M. Rodriguez-Peralvarez, D. Patch, J. O'Beirne, D. Thorburn, T. Luong, K. Rolles, B. Davidson, P. A. McCormick, P. Hayes, A. K. Burroughs, Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes, Gut, 2014, 63, 6, 1005

    CrossRef

  11. 11
    G. Levy, F. G. Villamil, F. Nevens, H. J. Metselaar, P.-A. Clavien, G. Klintmalm, R. Jones, M. Migliaccio, H. Prestele, R. Orsenigo, REFINE: A Randomized Trial Comparing Cyclosporine A and Tacrolimus on Fibrosis After Liver Transplantation for Hepatitis C, American Journal of Transplantation, 2014, 14, 3
  12. 12
    Jinyang Gu, Xingyu Wu, Lei Lu, Shu Zhang, Jianling Bai, Jun Wang, Jun Li, Yitao Ding, Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials, Hepatology International, 2014, 8, 2, 198

    CrossRef

  13. 13
    John C. LaMattina, Mihaela P. Jason, Steven I. Hanish, Shane E. Ottmann, David K. Klassen, Darryn Potosky, William R. Hutson, Rolf N. Barth, Safety of Belatacept Bridging Immunosuppression in Hepatitis C–Positive Liver Transplant Recipients With Renal Dysfunction, Transplantation Journal, 2014, 97, 2, 133

    CrossRef

  14. You have free access to this content14
    Audrey Coilly, Bruno Roche, Didier Samuel, Current management and perspectives for HCV recurrence after liver transplantation, Liver International, 2013, 33,
  15. 15
    Alina M. Allen, W. Ray Kim, Joseph Larson, Edward V. Loftus, Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, 2013, 11, 12, 1655

    CrossRef

  16. 16
    Dennis Eurich, Sabine Boas-Knoop, Benjamin Struecker, Ruth Neuhaus, Peter Neuhaus, Marcus Bahra, Genetic Variants of STAT-4 Affect the Development of Graft Fibrosis After Liver Transplantation for HCV-Induced Liver Disease, Transplantation Journal, 2013, 95, 1, 203

    CrossRef

  17. 17
    Michael R. Charlton, How important is acute cellular rejection?, Liver Transplantation, 2013, 19, S2
  18. 18
    Emad H. Asham, Ahmed Kaseb, R. Mark Ghobrial, Management of Hepatocellular Carcinoma, Surgical Clinics of North America, 2013, 93, 6, 1423

    CrossRef

  19. 19
    Geeta S. Karnik, Kirti Shetty, Management of Recurrent Hepatitis C in Orthotopic Liver Transplant Recipients, Infectious Disease Clinics of North America, 2013, 27, 2, 285

    CrossRef

  20. 20
    Josh Levitsky, Gabriel C. Oniscu, Meeting report of the international liver transplantation society's 18th annual international congress: Hilton San Francisco Hotel, San Francisco, CA, May 16-19, 2012, Liver Transplantation, 2013, 19, 1
  21. 21
    Yasutsugu Takada, Toshimi Kaido, Katsuhiro Asonuma, Hiroyuki Sakurai, Shoji Kubo, Tetsuya Kiuchi, Yukihiro Inomata, Shuji Isaji, Hayami Tsumura, Satoshi Teramukai, Yoshihiro Matsubara, Satomi Sakabayashi, Shinji Uemoto, Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus–positive recipients of living donor liver transplantation, Liver Transplantation, 2013, 19, 8
  22. 22
    Angel Rubín, Marina Berenguer, Trasplante hepático: inmunosupresión personalizada en pacientes con hepatitis C y carcinoma hepatocelular, Gastroenterología y Hepatología, 2013, 36, 1, 48

    CrossRef

  23. 23
    Curtis L. Cetrulo, Radbeh Torabi, Joseph R. Scalea, Akira Shimizu, Angelo A. Leto Barone, Bradford C. Gillon, Masayuki Tasaki, David A. Leonard, Taylor A. Cormack, Vincenzo Villani, Mark A. Randolph, David H. Sachs, Kazuhiko Yamada, Vascularized Composite Allograft Transplant Survival in Miniature Swine, Transplantation Journal, 2013, 96, 11, 966

    CrossRef

  24. 24
    Anna Zignego, Carlo Giannini, Laura Gragnani, Alessia Piluso, Elisa Fognani, Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact, Journal of Translational Medicine, 2012, 10, 1, 158

    CrossRef

  25. 25
    Aaron James Chan, John R. Lake, Immunosuppression in HCV-positive liver-transplant recipients, Current Opinion in Organ Transplantation, 2012, 17, 6, 648

    CrossRef

  26. 26
    Nicholas A. Shackel, Looking into Pandora's box , Liver Transplantation, 2012, 18, 3
  27. 27
    Marina Berenguer, José-Antonio Pons, Rabbit anti-thymocyte globulin in liver transplantation: All that glitters is not gold, but 1000 patients are so many to dazzle, Liver Transplantation, 2012, 18, 7
  28. 28
    Lionel Rostaing, Faouzi Saliba, Yvon Calmus, Sébastien Dharancy, Olivier Boillot, Review article: Use of induction therapy in liver transplantation, Transplantation Reviews, 2012, 26, 4, 246

    CrossRef

  29. 29
    Shigeru Marubashi, Koji Umeshita, Toshimasa Asahara, Kenji Fujiwara, Hironori Haga, Takashi Hashimoto, Katsuyoshi Hatakeyama, Takafumi Ichida, Takashi Kanematsu, Masaki Kitajima, Kendo Kiyosawa, Masatoshi Makuuchi, Shinichi Miyagawa, Susumu Satomi, Yuji Soejima, Yasutsugu Takada, Noriaki Tanaka, Satoshi Teraoka, Morito Monden, Steroid-free living donor liver transplantation for HCV – a multicenter prospective cohort study in Japan, Clinical Transplantation, 2012, 26, 6
  30. 30
    H.B. Meadows, D.J. Taber, N.A. Pilch, S.M. Tischer, P.K. Baliga, K.D. Chavin, The Impact of Early Corticosteroid Withdrawal on Graft Survival in Liver Transplant Recipients, Transplantation Proceedings, 2012, 44, 5, 1323

    CrossRef

  31. 31
    Qiuwei Pan, Hugo W. Tilanus, Herold J. Metselaar, Harry L. A. Janssen, Luc J. W. van der Laan, Virus–drug interactions—molecular insight into immunosuppression and HCV, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 6, 355

    CrossRef

  32. 32
    Luit Penninga, André Wettergren, Colin H Wilson, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Antibody induction versus corticosteroid induction for liver transplant recipients, The Cochrane Library,
  33. 33
    Luit Penninga, André Wettergren, Colin H Wilson, An-Wen Chan, Daniel A Steinbrüchel, Christian Gluud, Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients, The Cochrane Library,
  34. 34
    Nadim Mahmud, Burcin Taner, Nasimul Ahsan, Basiliximab (Simulect®) and Daclizumab (Zenapax®),
  35. 35
    Matthew H. Levine, Sandy Feng, Clinical Allograft Rejection Syndromes in Liver Transplantation,
  36. 36
    Samir Parekh, James R. Spivey, Recurrent Disease after Liver Transplantation,